{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:00:14Z","timestamp":1756810814758,"version":"3.41.2"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":705,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Manhattan Eye Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Rosacea is a cutaneous disease that may secondarily affect the ocular surface. Due to the vision threatening, cosmetic, psychological, and work productivity impact, the identification of cellular targets that govern rosacea would enhance our understanding of the biology of the disease and delineate targets for therapeutic manipulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To characterize the involvement of SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) in the pathogenesis of rosacea.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Specimens from elective ectropion surgery (n = 20) were processed from patients with rosacea (n = 10) and control patients (n = 10). Immunohistochemistry (IHC) and quantitative western blotting (WB) were performed to identify and quantify the presence of SHP2 and 4G10 (a phosphotyrosine antibody) in rosacea compared to normal tissue. IHC samples were graded according to an intensity scale (0\u20134). Mann-Whitney statistical analyses were performed via a dedicated computerized software package.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>On WB, SHP2 was expressed in higher concentrations in rosacea specimens (p &amp;lt; 0.05). On IHC, SHP2 was enriched in the epidermis in rosacea (p &amp;lt; 0.05), although 4G10 levels were not statistically significantly different between the two groups (p &amp;gt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>SHP2 is enriched in cutaneous specimens of rosacea, suggesting a critical role for this protein in the disease and indicating a modifiable therapeutic moiety.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/ski2.190","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T10:21:25Z","timestamp":1668680485000},"source":"Crossref","is-referenced-by-count":1,"title":["SH2 Domain-Containing Protein Tyrosine Phosphatase-2 is Enriched in Eyelid Specimens of Rosacea"],"prefix":"10.1093","volume":"3","author":[{"given":"Apoorv","family":"Chebolu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Lions Eye Institute , Albany, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon Bossardi","family":"Ramos","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Albany Medical Center , Albany, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilaka","family":"Arunachalam","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Lions Eye Institute , Albany, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro Pablo","family":"Adam","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Physiology, Albany Medical Center , Albany, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Wladis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Lions Eye Institute , Albany, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"5","key":"2025010818144315500_ski2190-bib-0001","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/J.1468-3083.2009.03132.X","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl. 3","key":"2025010818144315500_ski2190-bib-0002","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1016\/S0151-9638(11)70089-8","article-title":"Clinical presentations and classification of rosacea","volume":"138","author":"Jansen","year":"2011","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"2025010818144315500_ski2190-bib-0003","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.JAAD.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2025010818144315500_ski2190-bib-0004","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/J.JAAD.2017.09.016","article-title":"Comorbidities in rosacea: a systematic review and update","volume":"78","author":"Haber","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2025010818144315500_ski2190-bib-0005","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/J.JAAD.2016.12.043","article-title":"The burden of skin disease in the United States","volume":"76","author":"Lim","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025010818144315500_ski2190-bib-0006","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2019.01.018","article-title":"Nuclear factor kappa-B is enriched in eyelid specimens of rosacea: implications for pathogenesis and therapy","volume":"201","author":"Wladis","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2025010818144315500_ski2190-bib-0007","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.survophthal.2017.07.005","article-title":"Treatment of ocular rosacea","volume":"63","author":"Wladis","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"2025010818144315500_ski2190-bib-0008","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/J.JTOS.2021.08.017","article-title":"Immune signaling in rosacea","volume":"22","author":"Wladis","year":"2021","journal-title":"Ocul Surf"},{"issue":"4","key":"2025010818144315500_ski2190-bib-0009","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/IOP.0B013E31824DD9D4","article-title":"Molecular biologic assessment of cutaneous specimens of ocular rosacea","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"2025010818144315500_ski2190-bib-0010","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/01676830.2021.1905668","article-title":"Myeloid differentiation factor 88 expression in eyelid specimens of rosacea","volume":"41","author":"Wladis","year":"2021","journal-title":"Orbit"},{"issue":"OCT","key":"2025010818144315500_ski2190-bib-0011","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02468","article-title":"SHP-2 in lymphocytes' cytokine and inhibitory receptor signaling","volume":"10","author":"Niogret","year":"2019","journal-title":"Front Immunol"},{"key":"2025010818144315500_ski2190-bib-0012","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0065-230X(10)06002-1","volume-title":"Advances in cancer research","author":"Grossmann","year":"2010"},{"issue":"9","key":"2025010818144315500_ski2190-bib-0013","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045596","article-title":"Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes","volume":"7","author":"Mamik","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2025010818144315500_ski2190-bib-0014","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-\u03baB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2025010818144315500_ski2190-bib-0015","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1084\/jem.193.1.101","article-title":"Modulation of the nuclear factor \u03baB pathway by SHP-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor","volume":"193","author":"You","year":"2001","journal-title":"J Exp Med"},{"issue":"10","key":"2025010818144315500_ski2190-bib-0016","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.4049\/jimmunol.179.10.7101","article-title":"MAPK p38 regulates transcriptional activity of NF-\u03baB in primary human astrocytes via acetylation of p65","volume":"179","author":"Saha","year":"2007","journal-title":"J Immunol"},{"issue":"6","key":"2025010818144315500_ski2190-bib-0017","article-title":"Update on the management of rosacea from the American Acne & Rosacea Society (AARS)","volume":"12","author":"Del Rosso","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"2025010818144315500_ski2190-bib-0018","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/J.JPROT.2015.04.006","article-title":"Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics","volume":"127","author":"van der Mijn","year":"2015","journal-title":"J Proteomics"},{"key":"2025010818144315500_ski2190-bib-0019","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2019.104595","article-title":"Targeting SHP2 as a promising strategy for cancer immunotherapy","volume":"152","author":"Liu","year":"2020","journal-title":"Pharmacol Res"},{"key":"2025010818144315500_ski2190-bib-0020","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMECH.2021.113264","article-title":"Targeting SHP2 as a therapeutic strategy for inflammatory diseases","volume":"214","author":"Liu","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"12","key":"2025010818144315500_ski2190-bib-0021","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1248\/BPB.B18-00558","article-title":"Nitric oxide is involved in activation of toll-like receptor 4 signaling through tyrosine nitration of Src homology protein tyrosine phosphatase 2 in murine dextran sulfate-induced colitis","volume":"41","author":"Tun","year":"2018","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"2025010818144315500_ski2190-bib-0022","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0153289","article-title":"Investigating the role of TNF-\u03b1 and IFN-\u03b3 activation on the dynamics of iNOS gene expression in LPS stimulated macrophages","volume":"11","author":"Salim","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"2025010818144315500_ski2190-bib-0023","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.4049\/JIMMUNOL.1200197","article-title":"SHP2 plays an important role in acute cigarette smoke-mediated lung inflammation","volume":"189","author":"Li","year":"2012","journal-title":"J Immunol"},{"issue":"2","key":"2025010818144315500_ski2190-bib-0024","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/ALCALC\/AGW098","article-title":"The role of NFkB in drug addiction: beyond inflammation","volume":"52","author":"Nennig","year":"2017","journal-title":"Alcohol Alcohol"},{"issue":"9","key":"2025010818144315500_ski2190-bib-0025","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/carcin\/23.9.1511","article-title":"Cigarette smoke condensate activates nuclear transcription factor-\u03baB through phosphorylation and degradation of I\u03baB\u03b1: correlation with induction of cyclooxygenase-2","volume":"23","author":"Anto","year":"2002","journal-title":"Carcinogenesis"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ski2.190","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ski2.190","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/3\/1\/ski2.190\/59935170\/skinhd_3_1_e190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/3\/1\/ski2.190\/59935170\/skinhd_3_1_e190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:14:52Z","timestamp":1736360092000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.190\/7755667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.190","relation":{},"ISSN":["2690-442X"],"issn-type":[{"type":"electronic","value":"2690-442X"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2022,11,17]]},"article-number":"ski2.190"}}